Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
OtherClinical Investigations (Human)

Simulation of low dose protocols for myocardial perfusion 82Rubidium imaging

Martin Lyngby Lassen, Yuka Otaki, Paul Kavanagh, Robert Jack Henry Miller, Daniel S. Berman and Piotr J. Slomka
Journal of Nuclear Medicine January 2021, jnumed.120.252429; DOI: https://doi.org/10.2967/jnumed.120.252429
Martin Lyngby Lassen
Cedars-Sinai Medical Center, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuka Otaki
Cedars-Sinai Medical Center, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Kavanagh
Cedars-Sinai Medical Center, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Jack Henry Miller
Cedars-Sinai Medical Center, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert Jack Henry Miller
Daniel S. Berman
Cedars-Sinai Medical Center, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Piotr J. Slomka
Cedars-Sinai Medical Center, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.120.252429
DOI 
https://doi.org/10.2967/jnumed.120.252429
PubMed 
33419943

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online January 8, 2021.

Copyright & Usage 
Copyright © 2021 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Martin Lyngby Lassen,
  2. Yuka Otaki,
  3. Paul Kavanagh,
  4. Robert Jack Henry Miller,
  5. Daniel S. Berman and
  6. Piotr J. Slomka
  1. Cedars-Sinai Medical Center, United States
  1. For correspondence or reprints contact: Piotr J. Slomka, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, United States. E-mail: piotr.slomka@cshs.org

Article usage

Article usage: to

AbstractFullPdf
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (2)
Journal of Nuclear Medicine
Vol. 62, Issue 2
February 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Simulation of low dose protocols for myocardial perfusion 82Rubidium imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Simulation of low dose protocols for myocardial perfusion 82Rubidium imaging
Martin Lyngby Lassen, Yuka Otaki, Paul Kavanagh, Robert Jack Henry Miller, Daniel S. Berman, Piotr J. Slomka
Journal of Nuclear Medicine Jan 2021, jnumed.120.252429; DOI: 10.2967/jnumed.120.252429

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Simulation of low dose protocols for myocardial perfusion 82Rubidium imaging
Martin Lyngby Lassen, Yuka Otaki, Paul Kavanagh, Robert Jack Henry Miller, Daniel S. Berman, Piotr J. Slomka
Journal of Nuclear Medicine Jan 2021, jnumed.120.252429; DOI: 10.2967/jnumed.120.252429
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta-analysis
  • QUANTIFICATION OF METASTATIC PROSTATE CANCER WHOLE-BODY TUMOR BURDEN WITH FDG PET PARAMETERS AND ASSOCIATIONS WITH OVERALL SURVIVAL AFTER FIRST LINE ABIRATERONE OR ENZALUTAMIDE: A SINGLE- CENTER RETROSPECTIVE COHORT STUDY
Show more Clinical Investigations (Human)

Clinical (Cardiovascular)

  • Cardiac Beta-Adrenergic Receptor Downregulation, Evaluated by Cardiac Positron Emission Tomography, in Chronotropic Incompetence
  • Diagnostic Performance of PET vs. SPECT Myocardial Perfusion Imaging in Patients with Smaller Left Ventricles: a Substudy of the 18F-Flurpiridaz Phase-III Clinical Trial
Show more Clinical (Cardiovascular)

Similar Articles

Keywords

  • Cardiology (basic/technical)
  • Cardiology (clinical)
  • Image Reconstruction
  • low dose
  • myocardial perfusion imaging
  • Positron Emission Tomography
  • rubidium
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire